Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys

Toxicology

Volumn 112, Issue 3, 1996, Pages 183-194

  Busker, R W ^a   Zijlstra, J J ^a   Philippens, I H C H M ^a   Groen, B ^a   Melchers, B P C ^a  

^a TNO   (Netherlands)

Author keywords

Acetylcholines terase; Behavioural incapacitation; Guinea pigs; HI 6; Marmosets; Pharmacokinetics; Repeated dose; Soman

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ACETYLCHOLINESTERASE; ATROPINE; SOMAN;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GUINEA PIG; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MARMOSET; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; TREMOR;

ANIMALIA; CAVIA; CAVIA PORCELLUS; MARMOSETS; SUS SCROFA;

EID: 0030565591     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(96)03358-6     Document Type: Article

References (20)

1. Busker, R.W., Zijlstra, J.J., Van der Wiel, H.J., Melchers, B.P.C. and Van Helden, H.P.M. (1991) Organophosphate poisoning. A method to test therapeutic effects of oximes other than acetylcholinesterase reactivation. Toxicology 69, 331-334.
2. Clement, J.G., Simons, K.J. and Briggs, C.J. (1988) Effect of poisoning by soman on the serum halflife of the cholinesterase reactivator HI-6 in mice. Biopharmacol. Drug Dispos. 9, 177-186.
3. Ecobichon, D.J., Comeau, A.M., O'Neil, W.M. and Marshall, W.D. (1990) Kinetics, distribution, and biotransformation of the chemical HI-6 in the rat, dog, and rhesus monkey. Can. J. Physiol. 68, 614-621.
4. Hamilton, M.C. and Lundy, P.M. (1989) HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch. Toxicol. 63, 144-149.
5. Kepner, L.A. and Wolthuis, O.L. (1978) A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents. Eur. J. Pharmacol. 48, 377-382.
6. Kusic, R., Boskovic, B., Voivodic, V. and Jovanovic, D. (1985) HI-6 in man: blood levels, urinary excretion and tolerance after intramuscular administration of the oxime to healthy volunteers. Fundam. Appl. Toxicol. 5, s89-s97.
7. Kusic, R., Jovanovic, D., Randlelovic, S., Joksovic, D., Todorovic, V., Boskovic, B., Jokanovic, M. and Voivodic, V. (1991) HI-6 in man: efficacy of the oxime in poisoning by organophosphorus insecticides. Hum. Exp. Toxicol. 10, 113-118.
8. Ligtenstein, D.A. and Kossen S.P. (1983) Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration. Toxicol. Appl. Pharmacol. 71, 177-183.
9. Lundy, P.M., Goulet, J.C. and Hand, B.T. (1989) Hormone-and dose schedule-dependent protection by HI-6 against soman and tabun poisoning. Fundam. Appl. Toxicol. 12, 595-603.
10. Melchers, B.P.C., van der Laaken, A.L. and Van Helden, H.P.M. (1991) On the mechanism whereby HI-6 improves neuromuscular function after oxime-resistant acetylcholinesterase inhibition and subsequent impairment of neuromuscular transmission. Eur. J. Pharmacol. 200, 331-337.
11. Melchers, B.P.C., Philippens, I.H.C.H.M. and Wolthuis, O.L. (1994a) Efficacy of HI-6 and HL-7 in preventing incapacitation following nerve agent poisoning. Pharmacol. Biochem. Behav. 49, 781-788.
12. Melchers, B.P.C., van der Laaken, A.L., Busker, R.W., Bruijnzeel, P.L.B. and van Helden, H.P.M. (1994b) Non-reactivating effects of HI-6 on hippocampal neurotransmission. Arch. Toxicol. 65, 118-126.
13. Natrella, G.A. (1963) Experimental Statistics. National Bureau of Standards, Handbook 91, Government Printing Agency, Washington, DC.
14. Philippens, I.H.C.H.M., Melchers, B.P.C. and Wolthuis, O.L. (1992) Active avoidance in guinea pigs: effects of physostigmine and scopolamine. Pharmacol. Bioch. Behav. 42, 285-289.
15. Puu, G., Arturson, E. and Bucht, G. (1986) Reactivation of nerve agent inhibited human acetylcholinesterase by obidoxime. Biochem. Pharmacol. 35, 1505-1507.
16. Talbot, B.G., Anderson, D.R., Harris, L.W., Yarbrough, L.W. and Lennox, W.J. (1988) A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem. Toxicol. 11, 289-305.
17. Van Helden, H.P.M., De Lange, J., Busker, R.W. and Melchers, B.P.C. (1991) Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation. Arch. Toxicol. 65, 586-593.
18. Van Helden, H.P.M., Van der Wiel, H.J., De Lange, J., Busker, R.W., Melchers, B.P.C. and Wolthuis, O.L. (1992) Therapeutic efficacy of HI-6 in soman-poisoned marmoset monkeys. Toxicol. Appl. Pharmacol. 115, 50-56.
19. Van Helden, H.P.M., Zijlstra, J.J., van der Wiel, H.J., Melchers, B.P.C. and Busker, R.W. (1994) Comparison of the therapeutic effects and pharmacokinetics of HI-6, HL-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase-inhibition in rats. Arch. Toxicol. 68, 224-230.
20. Wolthuis, O.L. (1991) Some animal models and their probability of extrapolation to man. Neurosci. Biobehav. Rev. 15, 25-34.